CITIUS PHARMACEUTICALS INC (CTXR) Stock Income Statement
NASDAQ:CTXR • US17322U3068
Current stock price
0.8256 USD
+0.01 (+1.8%)
At close:
0.8256 USD
0 (0%)
After Hours:
| TTM (2025-12-31) | 2025 (2025-9-30) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.94M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | 2.97M | 2.31M | 287.00K | N/A | N/A | |||
| Operating Expenses | 40.66M | 38.53M | 42.00M | 36.73M | 33.32M | |||
| Research and Development | 8.63M | 9.16M | 11.91M | 14.82M | 17.66M | |||
| Selling, General, and Administrative Expenses | 31.46M | 29.37M | 30.09M | 21.91M | 15.66M | |||
| Operating Income | -37.51M | -38.53M | -42.00M | -36.73M | -33.32M | |||
| Interest Income/Expense | -290.70K | -157.70K | 758.00K | 1.18M | 250.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Non Recurring Items | N/A | 0.00 | 2.39M | 3.59M | 0.00 | |||
| Income Before Taxes | -37.80M | -38.68M | -38.85M | -31.97M | -33.06M | |||
| Income Tax | 1.06M | 1.06M | 576.00K | 576.00K | 580.00K | |||
| Net Income | -35.89M | -37.43M | -40.19M | -33.69M | -33.64M | |||
| EBITDA | N/A | N/A | -41.99M | -36.73M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.92 | -3.38 | -5.97 | -5.57 | -0.23 | |||
| Non GAAP EPS | N/A | -4.09 | -5.84 | N/A | -5.50 | |||
| Statistics | ||||||||
| Profit Margin | -909.88% | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | -950.92% | N/A | N/A | N/A | N/A | |||
All data in USD